Đang chuẩn bị liên kết để tải về tài liệu:
USMPep: Universal sequence models for major histocompatibility complex binding affinity prediction

Immunotherapy is a promising route towards personalized cancer treatment. A key algorithmic challenge in this process is to decide if a given peptide (neoepitope) binds with the major histocompatibility complex (MHC). This is an active area of research and there are many MHC binding prediction algorithms that can predict the MHC binding affinity for a given peptide to a high degree of accuracy. |